Le système dopaminergique (DA) méso-corticolimbique du cerveau, qui prend son origine dans l'aire tegmentaire ventrale (ATV), est fortement impliqué dans les comportements motivés et la toxicomanie. Les drogues d'abus activent ce système et y induisent une plasticité synaptique de longue durée. Les neurones DA de l'ATV reçoivent sur leur arborisation dendritique une grande densité de terminaisons glutamatergiques. Les drogues d'abus induisent une potentialisation à long terme (PLT) de ces contacts glutamatergiques. La PLT est une augmentation prolongée de la transmission synaptique, qui semble sous-tendre la mémoire et l'apprentissage. Les endocannabinoïdes (ECs) sont des neurotransmetteurs qui agissent de façon rétrograde sur des récepteurs présynaptiques (CB1) pour diminuer la libération des neurotransmetteurs comme le glutamate. Les neurones libèrent les ECs à partir de leur compartiment somatodendritique suite à une stimulation des afférences et la dépolarisation membranaire qui s’ensuit. La neurotensine (NT) est un neuropeptide retrouvé de façon abondante dans le système DA du cerveau. Il a été découvert que la NT peut induire la libération des ECs dans le striatum. En faisant appel à une combinaison d’approches immunohistochimique, électrophysiologique et pharmacologique chez la souris, nous avons confirmé dans la première étude de cette thèse la présence des récepteurs CB1 sur les terminaisons glutamatergiques des neurones DA de l'ATV, et avons montré que leur activation induit une diminution de la libération de glutamate. Par ailleurs, nous avons montré que des trains de stimulation peuvent induire la libération des ECs. Nous avons découvert qu'en présence d'un antagoniste des récepteurs CB1, il y a facilitation de l’induction de la PLT. Cette observation suggère que les ECs ont un effet inhibiteur sur l’induction de la PLT, plutôt que sur son expression. Nous avons déterminé que le 2-arachidonoylglycerol (2-AG) est l’EC qui est principalement responsable de cette action inhibitrice. Finalement, la PLT induite en présence d’un antagoniste CB1 est aussi dépendante d'une activation des récepteurs NMDA du glutamate. Les travaux réalisés dans la deuxième étude de cette thèse ont montré que la NT est présente dans une sous-population de terminaisons axonales glutamatergiques dans l’ATV. Une application exogène de NT induit une diminution prolongée de l'amplitude des courants postsynaptiques excitateurs (CPSEs). Cette diminution est bloquée en présence d'un antagoniste non-sélectif des récepteurs à la NT, ainsi qu'en présence d'un antagoniste sélectif pour le récepteur de NT de type 1 (NTS1). Confirmant l’implication d’une production d’ECs, la baisse des CPSEs par la NT a été bloquée en présence d’un antagoniste des récepteurs CB1 ou d’un bloqueur de la synthèse de 2-AG. La chélation du calcium intracellulaire n'empêchait pas l’effet inhibiteur de la NT sur les CPSEs, cependant, l'inhibition des protéines G ou de la phospholipase C a complètement bloqué la dépression synaptique induite par la NT. Par ailleurs, nos travaux ont montré que la nature prolongée de la dépression synaptique induite par la NT exogène s’explique par une libération soutenue des ECs, et non pas à une activation prolongée des NTR. Finalement, notre observation qu’un antagoniste des récepteurs de la NT ne facilite pas l’induction de la PLT, comme le fait un antagoniste du récepteur CB1, suggère que la stimulation répétitive des afférences glutamatergiques nécessaire à l’induction de la PLT n’induit pas de libération des ECs via la libération de NT, nous permettant ainsi de conclure que la sécrétion de NT n'agit pas dans ces conditions comme un facteur de régulation négative de la PLT. / The meso-corticolimbic dopamine (DA) system of the brain, originating in the ventral tegmental area (VTA), is strongly implicated in reward, motivation and drug addiction. Drugs of abuse activate this system and cause significant long term plasticity. DA neurons in the VTA receive are densely innervated by glutamatergic inputs. All major classes of drugs of abuse have been found to cause a long term potentiation (LTP) of glutamate transmission onto DA neurons of the VTA. LTP is an enduring increase of synaptic transmission, hypothesized to underlie memory and learning. Endocannabinoids (ECs) are transmitters that act in a retrograde fashion on pre-synaptic receptors leading to a decrease in neurotransmitter release. DA neurons can release ECs from their somatodendritic compartment in response to afferent stimulation or depolarization. Neurotensin (NT) is a neuropeptide that presents an extensive interaction with the DA system. It was discovered that NT can induce production of ECs in the striatum. In the first study of this thesis, we used a combination of immunohistochemical, pharmacological and electrophysiological techniques in mouse brain slices to demonstrate that CB1 EC receptors are present on glutamatergic afferents to DA neurons. Their activation induces a depression of glutamate release. We further showed that trains of afferent stimulation induce EC release from DA neurons and that in the presence of the CB1 antagonist AM251, there is a marked facilitation of the induction of LTP, suggesting that ECs produced in response to activation of glutamate synapses normally negatively regulate the induction, but not the expression of LTP. Finally, we found that 2-arachidonoylglycerol (2-AG) is the main EC implicated in this negative regulation of LTP and that LTP induced in the presence of a CB1 receptor antagonist is otherwise also dependent on NMDA glutamate receptors. In the second study, we report that NT is present in a subset of glutamatergic axon terminals in the VTA and that activation of NT receptors by exogenous NT induces a long-lasting decrease of the amplitude of excitatory postsynaptic currents (EPSCs) in VTA DA neurons. This decrease was blocked by a broad-spectrum NTR antagonist, as well as by a specific antagonist of the type 1 NT receptor NTS1. The decrease was also blocked when CB1 receptors or 2-AG synthesis were blocked. Chelating intracellular calcium had no effect, but inhibiting G-proteins or phospholipase C blocked NT-mediated synaptic depression. The long-lasting nature of the synaptic depression induced by NT was due to protracted EC release and not to prolonged NT receptor activation. Finally, our observation that a NT receptor antagonist did not facilitate LTP induction, as did a CB1 receptor antagonist, suggests that repetitive stimulation of glutamatergic afferents required to induce LTP does not cause EC production through the release of NT, thus allowing us to conclude that secretion of NT does not act under such conditions as a negative regulator of LTP.

Using drugs such as alcohol and morphine among others can be addictive in some individuals, and progress into a substance abuse disorder. The mesolimbic dopaminergic system (MD-system) is involved in the reward process during the development of drug addiction. The MD-system is critical for survival and affects different behaviors in both man and animal. Neurochemical pathways drive for instance physical activity, food intake, love and reproduction and are part of the natural reward process involved partly in the release of dopamine (DA) into frontal lobes. Within the MD-system opioid receptors throughout the brain are affected by drug intake, and activation of these receptors modulate DA-release in brain regions involved in reward-behavior. The aim of this study was to evaluate gene expression of MOR and DOR within the endogenous opioid system (EO-system) in relation to voluntary physical activity, a natural reinforcer. Further on investigations of the drug alcohol was compared to the natural reinforcer sucrose using voluntary consumption. For both experiments qRT-PCR was used to measure mRNA levels of MOR and DOR from brain areas of interest. We found a small significant up regulation in NAc, PFC and VTA but for DOR in VTA a down regulation in gene expression of physical exercising mice. Additionally these two different genes OPRM1- and the OPRD1- gene are down regulated in VTA and NAc due to alcohol- and sugar-intake. This implicate that the natural reward system and their ORs point in the direction of earlier findings; the opioid receptors have a key role in regulate alcohol intake and the natural rewarding stimuli as food intake.

Le système dopaminergique (DA) méso-corticolimbique du cerveau, qui prend son origine dans l'aire tegmentaire ventrale (ATV), est fortement impliqué dans les comportements motivés et la toxicomanie. Les drogues d'abus activent ce système et y induisent une plasticité synaptique de longue durée. Les neurones DA de l'ATV reçoivent sur leur arborisation dendritique une grande densité de terminaisons glutamatergiques. Les drogues d'abus induisent une potentialisation à long terme (PLT) de ces contacts glutamatergiques. La PLT est une augmentation prolongée de la transmission synaptique, qui semble sous-tendre la mémoire et l'apprentissage. Les endocannabinoïdes (ECs) sont des neurotransmetteurs qui agissent de façon rétrograde sur des récepteurs présynaptiques (CB1) pour diminuer la libération des neurotransmetteurs comme le glutamate. Les neurones libèrent les ECs à partir de leur compartiment somatodendritique suite à une stimulation des afférences et la dépolarisation membranaire qui s’ensuit. La neurotensine (NT) est un neuropeptide retrouvé de façon abondante dans le système DA du cerveau. Il a été découvert que la NT peut induire la libération des ECs dans le striatum. En faisant appel à une combinaison d’approches immunohistochimique, électrophysiologique et pharmacologique chez la souris, nous avons confirmé dans la première étude de cette thèse la présence des récepteurs CB1 sur les terminaisons glutamatergiques des neurones DA de l'ATV, et avons montré que leur activation induit une diminution de la libération de glutamate. Par ailleurs, nous avons montré que des trains de stimulation peuvent induire la libération des ECs. Nous avons découvert qu'en présence d'un antagoniste des récepteurs CB1, il y a facilitation de l’induction de la PLT. Cette observation suggère que les ECs ont un effet inhibiteur sur l’induction de la PLT, plutôt que sur son expression. Nous avons déterminé que le 2-arachidonoylglycerol (2-AG) est l’EC qui est principalement responsable de cette action inhibitrice. Finalement, la PLT induite en présence d’un antagoniste CB1 est aussi dépendante d'une activation des récepteurs NMDA du glutamate. Les travaux réalisés dans la deuxième étude de cette thèse ont montré que la NT est présente dans une sous-population de terminaisons axonales glutamatergiques dans l’ATV. Une application exogène de NT induit une diminution prolongée de l'amplitude des courants postsynaptiques excitateurs (CPSEs). Cette diminution est bloquée en présence d'un antagoniste non-sélectif des récepteurs à la NT, ainsi qu'en présence d'un antagoniste sélectif pour le récepteur de NT de type 1 (NTS1). Confirmant l’implication d’une production d’ECs, la baisse des CPSEs par la NT a été bloquée en présence d’un antagoniste des récepteurs CB1 ou d’un bloqueur de la synthèse de 2-AG. La chélation du calcium intracellulaire n'empêchait pas l’effet inhibiteur de la NT sur les CPSEs, cependant, l'inhibition des protéines G ou de la phospholipase C a complètement bloqué la dépression synaptique induite par la NT. Par ailleurs, nos travaux ont montré que la nature prolongée de la dépression synaptique induite par la NT exogène s’explique par une libération soutenue des ECs, et non pas à une activation prolongée des NTR. Finalement, notre observation qu’un antagoniste des récepteurs de la NT ne facilite pas l’induction de la PLT, comme le fait un antagoniste du récepteur CB1, suggère que la stimulation répétitive des afférences glutamatergiques nécessaire à l’induction de la PLT n’induit pas de libération des ECs via la libération de NT, nous permettant ainsi de conclure que la sécrétion de NT n'agit pas dans ces conditions comme un facteur de régulation négative de la PLT. / The meso-corticolimbic dopamine (DA) system of the brain, originating in the ventral tegmental area (VTA), is strongly implicated in reward, motivation and drug addiction. Drugs of abuse activate this system and cause significant long term plasticity. DA neurons in the VTA receive are densely innervated by glutamatergic inputs. All major classes of drugs of abuse have been found to cause a long term potentiation (LTP) of glutamate transmission onto DA neurons of the VTA. LTP is an enduring increase of synaptic transmission, hypothesized to underlie memory and learning. Endocannabinoids (ECs) are transmitters that act in a retrograde fashion on pre-synaptic receptors leading to a decrease in neurotransmitter release. DA neurons can release ECs from their somatodendritic compartment in response to afferent stimulation or depolarization. Neurotensin (NT) is a neuropeptide that presents an extensive interaction with the DA system. It was discovered that NT can induce production of ECs in the striatum. In the first study of this thesis, we used a combination of immunohistochemical, pharmacological and electrophysiological techniques in mouse brain slices to demonstrate that CB1 EC receptors are present on glutamatergic afferents to DA neurons. Their activation induces a depression of glutamate release. We further showed that trains of afferent stimulation induce EC release from DA neurons and that in the presence of the CB1 antagonist AM251, there is a marked facilitation of the induction of LTP, suggesting that ECs produced in response to activation of glutamate synapses normally negatively regulate the induction, but not the expression of LTP. Finally, we found that 2-arachidonoylglycerol (2-AG) is the main EC implicated in this negative regulation of LTP and that LTP induced in the presence of a CB1 receptor antagonist is otherwise also dependent on NMDA glutamate receptors. In the second study, we report that NT is present in a subset of glutamatergic axon terminals in the VTA and that activation of NT receptors by exogenous NT induces a long-lasting decrease of the amplitude of excitatory postsynaptic currents (EPSCs) in VTA DA neurons. This decrease was blocked by a broad-spectrum NTR antagonist, as well as by a specific antagonist of the type 1 NT receptor NTS1. The decrease was also blocked when CB1 receptors or 2-AG synthesis were blocked. Chelating intracellular calcium had no effect, but inhibiting G-proteins or phospholipase C blocked NT-mediated synaptic depression. The long-lasting nature of the synaptic depression induced by NT was due to protracted EC release and not to prolonged NT receptor activation. Finally, our observation that a NT receptor antagonist did not facilitate LTP induction, as did a CB1 receptor antagonist, suggests that repetitive stimulation of glutamatergic afferents required to induce LTP does not cause EC production through the release of NT, thus allowing us to conclude that secretion of NT does not act under such conditions as a negative regulator of LTP.

Anxiety is an affective state defined by heightened arousal and unease in the absence of a clear and present fear-inducing stimulus. Chronic and inappropriate anxiety leads to anxiety disorders, the most common class of human mental disorder. Recent work suggests projections to the ventral tegmental area (VTA), are critical for anxiety behavior expression. However, the relationship between efferent VTA projections and anxiety is unclear. This thesis resolves anxiety circuitry connecting the dopaminergic (DAergic) VTA to the interpeduncular nucleus (IPN), coined the mesointerpeduncular circuit. I hypothesize the mesointerpeduncular circuit affects anxiety through the release of anxiogenic corticotropin releasing factor (CRF) during nicotine withdrawal and anxiolytic dopamine (DA) during drug naïve behavior. Electrophysiological and pharmacological data suggest CRF release from the DAergic VTA during nicotine withdrawal activates CRF receptor 1 (CRFR1) potentiating the glutamatergic activation of “Type 2” neurons and anxiety-like behavior in mice. However, in nicotine naïve conditions CRF production is negligible. Instead, in vivo DA release is anticorrelated with anxiety-like behaviors. Optogenetic stimulation and inhibition drives decreased and increased anxiety-like behaviors, respectively. Electrophysiological experiments reveal a complex interpeduncular microcircuit where D1-like DA receptor expressing “Type C” neurons in the caudal IPN (cIPN) regulate glutamatergic release in the ventral IPN (vIPN) through presynaptic GABA receptors. The result is propagation of the signal to excite “Type A” and inhibit “Type B” vIPN neurons. Finally, pharmacological activation or inhibition of interpeduncular D1-like DA receptors is sufficient to decrease and increase anxiety-like behaviors respectively. Thus, this circuit is important for modulating anxiety-like behavior.

Alcohol, recently named the most dangerous drug in the world, contributes to nearly 40% of violent crimes and fatal traffic accidents, increases risk of roughly 60 different diseases and injuries, and is responsible for 2.5 million deaths each year worldwide. Despite these staggering figures, treatments remain ineffective and riddled with adverse side effects, making successful use of even the most effective treatments unlikely. Moreover, many of the treatments, and the supporting research, have focused only on male subjects, despite sex differences in various alcohol-related behaviors. Human alcohol use is frequently accompanied by nicotine use, and vice versa, suggesting a common mechanism of the two drugs. In fact, alcohol may act through the same family of receptors as nicotine, the nicotinic acetylcholine receptors (nAChRs), eliciting similar activation of the reward pathway as nicotine and other drugs of abuse. Studies have shown that nAChRs containing the α4 and/or α6 subunits are involved in nicotine-induced activation of the reward pathway, leading to the hypothesis that these same receptor subtypes may be important for alcohol effects in the brain as well. Using male and female genetic mouse models and various behavioral assays, we have shown not only that these α4 and/or α6-containing nAChRs are involved in alcohol- related behaviors and activation of the reward pathway, but also show sex differences in this involvement. Uncovering the mechanism of alcohol in the brain, in males as well as in females, is an important step in developing targeted treatments for alcohol abuse.

L’objectif principal de mon projet de thèse a été d’identifier les mécanismes neuronaux adaptatifs se mettant en place au niveau des circuits de la récompense et des circuits activés en réponse à un stress aigu. Plus spécifiquement, nous avons étudié le rôle du noyau du lit de la strie terminale (BNST) au sein de ces deux circuits. Mon hypothèse est que le BNST appartient à un circuit de structures interconnectées dans lequel il intègre des informations contextuelles (hippocampe ventral) et des informations émotionnelles (cortex préfrontal médian) afin, d’une part, de réguler les niveaux d’anxiété innés ainsi que les réponses induites par les centres du stress suite à un épisode de stress aigu mais également, d’adapter l’activité des neurones dopaminergiques de l’aire tegmentale ventrale (VTA) en vue de motiver ou d’empêcher la reproduction d’un comportement associé à un stimulus récompensant ou aversif. Afin de tester cette hypothèse, nous avons mis en place et développé différents projets de recherche combinant des approches d’électrophysiologie in vivo, anatomiques et comportementales. Dans un premier temps, nous nous sommes intéressés au BNST en tant que structure clef participant à la régulation des centres de stress. Grâce à l’utilisation d’approches d’électrophysiologie in vivo chez la souris anesthésiée, nous avons montré qu’après l’exposition à un stress aigu, les neurones du BNST adaptent leur réponse suite à la stimulation du cortex préfrontal médian et passent d’une dépression à long terme (LTD) en situation contrôle à une potentialisation à long terme (LTP) après un stress aigu. Nous avons disséqué une partie des mécanismes permettant l’élaboration de ces plasticités grâce à l’utilisation de souris génétiquement modifiés pour le récepteur aux endocannabinoïdes de type 1 (CB1-R). Ainsi, nous avons trouvé que la LTD et la LTP mis en place dans le BNST sont médiées par le système endocannabinoïde via les récepteurs CB1. Ensuite, nous avons étudié le rôle du ventral subiculum (vSUB) dans la régulation des neurones du BNST ainsi que l’impact de l’activation de cette voie vSUB-BNST sur l’autre voie glutamatergique ILCx-BNST. Tout d’abord, nous avons montré par des approches électrophysiologiques et anatomiques, qu’un même neurone du BNST est capable d’intégrer des informations provenant à la fois du ventral subiculum et du cortex infralimbic (ILCx). Nous avons induit in vivo une LTP NMDA dépendante dans la voie vSUB-BNST suite à un protocole de stimulation haute fréquence dans le vSUB alors qu’en parallèle ce même protocole induit une LTD sur ces mêmes neurones dans la voie ILCx–BNST. Deplus, nous avons noté que ces adaptations plastiques se mettant en place dans le BNST suiteà une simple stimulation haute fréquence dans le vSUB permettent à long terme de diminuerles niveaux d’anxiété innés chez le rat. Enfin, nous avons mis en évidence que le BNST est un relai excitateur entre le vSUBet la VTA. Nous avons montré qu’une stimulation à haute fréquence dans le vSUBpotentialise in vivo l’activité des neurones dopaminergiques (DA) de la VTA. Or le vSUBne projette pas de manière directe sur les neurones DA de la VTA. Nous avons observé quece protocole de stimulation haute fréquence dans le vSUB induit dans un premier temps uneLTP NMDA dépendante dans les neurones du BNST projetant à la VTA qui est nécessairepour observer cette potentialisation des neurones DA. En dernier lieu, nous avons montréque cette potentialisation des neurones DA de la VTA augmente la réponse locomotrice à unchallenge avec de la cocaine.Ainsi, l’ensemble de ces projets nous ont permis de confirmer et de préciser lafonction majeure du BNST dans la régulation du stress et de l’anxiété ainsi que dans lecircuit de la motivation. / The main goal of my PhD was to identify the adaptive neuronal mechanismsdeveloping in the reward circuit and in the circuit implicated in the regulation of stressresponses. More specifically, we have studied the function of the bed nucleus of the striaterminalis (BNST) in both circuits.My hypothesis was that, the BNST belongs to interconnected circuits in whichintegrates contextual (from ventral hippocampus) and emotional informations (from medialprefrontal cortex). Thus, the BNST diffuses these informations in order to regulate the basalinnate level of anxiety and stress centers responses induced after acute stress exposure, butalso to adapt the activity of dopaminergic neurons of the ventral tegmental area (VTA) thatcan promote or prevent a behavioral task associated with a rewarding or aversive stimulus.To test this hypothesis, we decided to develop several research projects usingelectrophysiological, anatomical and behavioral approaches.Firstly, we focused our interest on the stress circuit in which the BNST is a keystructure which participates in regulating the responses of stress centers after acute stressexposure. By using in vivo electrophysiology approach in anesthetized mice, we haveshown that after acute restraint stress, BNST neurons adapt their plastic responses inducedby the tetanic stimulation of the medial prefrontal cortex: switch from long term depression(LTD) under control condition to long term potentiation (LTP) after acute stress condition.Furthermore, we demonstrated that both LTD and LTP are endocannabinoid dependent byusing genetic modified mice for the type 1 endocannabinoid receptors and localpharmacological approach in the BNST.In a second step, we studied the function of the ventral subiculum (vSUB) in theregulation of BNST neurons and the impact of the vSUB-BNST pathway activation on theother glutamatergic ILCx-BNST pathway. In a first set of experiments, we showed that asame single BNST neuron could integrate informations from both vSUB and the infralimbiccortex. By using high frequency stimulation (HFS) protocols, we induced in vivo NMDAdependentLTP in the vSUB-BNST pathway whereas the same protocol led to LTD in thesame BNST neurons in the ILCx-BNST pathway. Moreover, we noted single application ofHFS protocol in the vSUB induced a long term decrease of the basal innate level of anxietyin rats.Lastly, we presented the BNST as a key excitatory relay between the vSUB and theVTA. Here, we have shown that in vivo HFS protocols in the vSUB potentiate the activity ofdopaminergic (DA) neurons of the VTA. However, the vSUB does not directly project to theVTA. We observed that a HFS protocol in the vSUB first induce NMDA-dependent LTP inBNST neurons that project to the VTA, which is necessary to promote the potentiation of7VTA DA neurons. In the last step, we demonstrated in vivo that the potentiation of VTA DAneurons increases the locomotor response to cocaine challenge.All together, these projects allow us to confirm and detail the major function of theBNST in the regulation of stress and anxiety and also in the motivational circuit.

The basal ganglia are the key circuitry controlling movement and reward behavior. Both locomotion and reward-related behavior are also modified by dopaminergic input from the substantia nigra and the ventral tegmental area (VTA). If the basal ganglia are severed by lesion or in disease, such as in Parkinson’s disease, the affected individuals suffer from severe motor impairments and often of affective and reward-related symptoms. The subthalamic nucleus (STN) is a glutamatergic key area of the basal ganglia and a common target for deep brain stimulation in Parkinson’s disease to alleviate motor symptoms. The STN serves not only motoric, but also limbic and cognitive functions, which is often attributed to a tripartite anatomical subdivision. However, the functional output of both VTA and STN may rely more on intermingled subpopulations than on a strictly anatomical subdivision. In this doctoral thesis, the role of subpopulations within and associated with the basal ganglia is addressed from both a genetic and a behavioral angle. The identification of a genetically defined subpopulation within the STN, co-expressing Paired-like homeodomain transcription factor 2 (Pitx2) and Vesicular glutamate transport 2 (Vglut2), made it possible to conditionally reduce glutamatergic transmission from this subgroup of neurons and to investigate its influence on locomotion and motivational behavior, giving interesting insights into the mechanisms possibly underlying deep brain stimulation therapy and its side-effects. We address the strong influence of the Pitx2-Vglut2 subpopulation on movement, as well as the more subtle changes in reward-related behavior and the impact of the alterations on the reward-related dopaminergic circuitry. We also further elucidate the genetic composition of the STN by finding new markers for putative STN subpopulations, thereby opening up new possibilities to target those cells genetically and optogenetically. This will help in future to examine both STN development, function in the adult central nervous system and defects caused by specific deletion. Eventually identifying and characterizing subpopulations of the STN can contribute to the optimization of deep brain stimulation and help to reduce its side-effects, or even open up possibilities for genetic or optogenetic therapy approaches.

Neural activity in dopaminergic areas such as the ventral tegmental area is influenced by timing processes, in particular by the temporal expectation of rewards during Pavlovian conditioning. Receipt of a reward at the expected time allows to compute reward-prediction errors which can drive learning in motor or cognitive structures. Reciprocally, dopamine plays an important role in the timing of external events. Several models of the dopaminergic system exist, but the substrate of temporal learning is rather unclear. In this article, we propose a neuro-computational model of the afferent network to the ventral tegmental area, including the lateral hypothalamus, the pedunculopontine nucleus, the amygdala, the ventromedial prefrontal cortex, the ventral basal ganglia (including the nucleus accumbens and the ventral pallidum), as well as the lateral habenula and the rostromedial tegmental nucleus. Based on a plausible connectivity and realistic learning rules, this neuro-computational model reproduces several experimental observations, such as the progressive cancelation of dopaminergic bursts at reward delivery, the appearance of bursts at the onset of reward-predicting cues or the influence of reward magnitude on activity in the amygdala and ventral tegmental area. While associative learning occurs primarily in the amygdala, learning of the temporal relationship between the cue and the associated reward is implemented as a dopamine-modulated coincidence detection mechanism in the nucleus accumbens.

Neural activity in dopaminergic areas such as the ventral tegmental area is influenced by timing processes, in particular by the temporal expectation of rewards during Pavlovian conditioning. Receipt of a reward at the expected time allows to compute reward-prediction errors which can drive learning in motor or cognitive structures. Reciprocally, dopamine plays an important role in the timing of external events. Several models of the dopaminergic system exist, but the substrate of temporal learning is rather unclear. In this article, we propose a neuro-computational model of the afferent network to the ventral tegmental area, including the lateral hypothalamus, the pedunculopontine nucleus, the amygdala, the ventromedial prefrontal cortex, the ventral basal ganglia (including the nucleus accumbens and the ventral pallidum), as well as the lateral habenula and the rostromedial tegmental nucleus. Based on a plausible connectivity and realistic learning rules, this neuro-computational model reproduces several experimental observations, such as the progressive cancelation of dopaminergic bursts at reward delivery, the appearance of bursts at the onset of reward-predicting cues or the influence of reward magnitude on activity in the amygdala and ventral tegmental area. While associative learning occurs primarily in the amygdala, learning of the temporal relationship between the cue and the associated reward is implemented as a dopamine-modulated coincidence detection mechanism in the nucleus accumbens.

Indiana University-Purdue University Indianapolis (IUPUI) / Alcohol and cocaine are commonly co-abused drugs, and those meeting criteria for both cocaine and alcohol use disorders experience more severe behavioral and health consequences than those with a single disorder. Chronic alcohol (ethanol) drinking increased the reinforcing and dopamine (DA) neuronal stimulating effects of ethanol within mesolimbic regions of the central nervous system (CNS) of alcohol-preferring (P) rats. The objectives of the current study were to determine if chronic continuous ethanol drinking produced: (1) alterations in the sensitivity of the nucleus accumbens shell (AcbSh) to the reinforcing effects of cocaine, (2) changes in the magnitude and time course of the local stimulating effects of cocaine on posterior ventral tegmental area (pVTA) DA neurons, and (3) a persistence of alterations in the stimulating effects of cocaine after a period of protracted abstinence. Female P rats received continuous, free-choice access to water and 15% v/v ethanol for at least 10 wk (continuous ethanol-drinking; CE) or access to water alone (ethanol-naïve; N). A third group of rats received the same period of ethanol access followed by 30 d of protracted abstinence from ethanol (ethanol-abstinent; Ab). CE and Ab rats consumed, on average, 6-7 g/kg/d of ethanol. Animals with a single cannula aimed at the AcbSh responded for injections of cocaine into the AcbSh during four initial operant sessions. Cocaine was not present in the self-infused solution for the subsequent three sessions, and cocaine access was restored during one final session. Animals with dual ipsilateral cannulae aimed at the AcbSh and the pVTA were injected with pulsed microinfusions of cocaine into the pVTA while DA content was collected for analysis through a microdialysis probe inserted into the AcbSh. During the initial four sessions, neither CE nor N rats self-infused artificial cerebrospinal fluid (aCSF) or 0.1 mM cocaine into the AcbSh. CE, but not N, rats self-administered 0.5 mM cocaine into the AcbSh, whereas both groups self-infused concentrations of 1.0, 2.0, 4.0, or 8.0 mM cocaine. When cocaine access was restored in Session 8, CE rats responded more on the active lever and obtained more infusions of 0.5, 1.0, 2.0, or 4.0 mM cocaine compared to N rats. Microinjection of aCSF into the pVTA did not alter AcbSh DA levels in N, CE, or Ab rats. Microinjections of 0.25 mM cocaine into the pVTA did not significantly alter AcbSh DA levels in N animals, moderately increased DA levels in CE rats, and greatly increased DA levels in Ab rats. Microinjections of 0.5 mM cocaine into the pVTA modestly increased AcbSh DA levels in N animals, robustly increased DA levels in CE rats, and did not significantly alter DA levels in Ab rats. Microinjections of 1.0 or 2.0 mM cocaine into the pVTA modestly increased AcbSh DA levels in N animals but decreased DA levels in CE and Ab rats. Overall, long-term continuous ethanol drinking by P rats enhanced both the reinforcing effects of cocaine within the AcbSh and the stimulatory and inhibitory effects of cocaine on pVTA DA neurons. Alterations in the stimulatory and inhibitory effects of cocaine on pVTA DA neurons were not only enduring, but also enhanced, following a period of protracted abstinence from ethanol exposure. Translationally, prevention of chronic and excessive alcohol intake in populations with a genetic risk for substance abuse may reduce the likelihood of subsequent cocaine use.